APA (7th ed.) Citation

Ludwig, J., Federman, N., Anderson, P., Macy, M., Davis, L., Riedel, R., . . . Meyers, P. (2020). 1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma. Annals of Oncology, 31, S972. https://doi.org/10.1016/j.annonc.2020.08.1846

Chicago Style (17th ed.) Citation

Ludwig, J.A, et al. "1620O Phase I Study of TK216, a Novel Anti-ETS Agent for Ewing Sarcoma." Annals of Oncology 31 (2020): S972. https://doi.org/10.1016/j.annonc.2020.08.1846.

MLA (9th ed.) Citation

Ludwig, J.A, et al. "1620O Phase I Study of TK216, a Novel Anti-ETS Agent for Ewing Sarcoma." Annals of Oncology, vol. 31, 2020, p. S972, https://doi.org/10.1016/j.annonc.2020.08.1846.